(Date:11/5/2009)...,, Conference Call on Thursday, November 5, 200... VANCOUVER Nov. 5 /PRNewswire-FirstCall/ - OncoGen...any") (NASDAQ: OGXI ) today reported unaudited fi...ths ended September 30, 2009 and reviewed the Comp..., The following consolidated results reflect the...
(Date:11/5/2009)...,, SUNNYVALE, Calif., Nov. 5 /PRNewswire-FirstC...hat its executives will be speaking at the followi...participate via webcast. , , Credi... Thursday, 12 November, 2009 at 10 a.m. ...vestor Program, London, England, T...
(Date:11/5/2009)...,, FREMONT, Calif., Nov. 5 /PRNewswire-FirstCal...d: WGBS), a leading developer of state-of-the-art ...istopher Sears, Ph.D. has joined the company,s Sci...ed on designing and commercializing novel molecula...cations, and on the development of computational b...
(Date:11/5/2009)... Drug safety specialty fi... eLearning and Informatics earned the Certified Pr...P) credential from the American Society for Traini... Michelle Flewell has more than fifteen years of ...perience and is responsible for the development of...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8Cepheid to Webcast Upcoming Financial Presentations 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4...rs Special Protocol Assessment for Reviroc, AMSTE...hat it has successfully completed an End of Phase ... Administration (FDA). Reviroc is under,developmen...us graft in,bone marrow transplantations for end-s...e data from the completed phase II clinical Reviro...
...Calif., Dec. 19 AMDL, Inc., (Amex:,ADL), today an...nc., a,developer, manufacturer, and marketer of ph...ealthcare and personal care products, is set to op...al Care Center in Hangzhou,China. The state-of-the...,into a flagship JPGreen Health and Personal Care ...
...offers patients the chance to live twice as long w...ancing, BASEL, Switzerland, Dec. 19 Avastin (bev... approved today in Europe for the,first-line treat...RCC) in,combination with interferon (IFN), the cur...nal cell carcinoma (RCC) is a disease that kills o...
Other Biology Technology:Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc 2AMDL's First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China 2Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer 2Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer 3ECL Cell Attachment Matrix from Upstate
NucBuster Protein Extraction Kit from Novagen
DETACHaBEAD Mouse CD4 from Dynal Biotech
10% Normal Goat Serum from Invitrogen
Biology Products: